Valery Grinevich joins the ZI Mannheim as Department Head of "Neuropeptide research in psychiatry"
retreat

Prof. Dr. Valery Grinevich has joined the Central Institute for Mental Health (ZI) in Mannheim as Department Head for of the new department "Neuropeptide research in psychiatry". Valery was one of the first five Schaller Group leaders recruited by the Chica and Heinz Schaller Foundation in 2012 and since then headed his laboratory focusing on neuropeptide research. Since 2015, he is a principal investigator in the Heidelberg Pain Consortium, Project B02.

In Mannheim his department will focus on the dissection of the mechanisms of neuropeptide action in the brain, from molecular – via anatomical – to the whole organism level. They are employing viral, opto- and chemogenetical, electrophysiological  and behavioral approaches to study the effects of various neuropeptides (primarily oxytocin, OT) within the distinct brain regions controlling stress and fear responses, maternal and social behavior.

Excitingly, his group's most recent work was just published in Neuron:

"A Fear Memory Engram and Its Plasticity in the Hypothalamic Oxytocin System”, Neuron. 2019, doi:10.1016/j.neuron.2019.04.029.

News

  • ECNP Neuropsychopharmacology Award

    Congratulations to Prof. Dr. Valery Grinevich (Project B02)!

     

    Read more ...  
  • Silvia King Award 2021

    Congratulations to Dr. Johann Jende (Project A03)!

     

    Read more ...  
  • SFB1158 and NIKON BioImage Analysis Workshop

    Registration deadline extended until 30 April 2021

     

    Read more ...  
  • Latest research from Project B02

    (New paper published in Nature Neuroscience)

     

    Read more ...  
  • Webinar, "Multiomics Single Cell Analysis and Spatial Gene Expression Analysis of Intact Tissues"

    Register now for this webinar on February 17, 2021

     

    Read more ...